- According to federal requirements for drug take-back programs, the inner liner of a collection receptacle must be:
Answer: Waterproof, tamper-evident, and tear-resistant.
DEA regulations specify that the inner liner of a collection receptacle must have features that ensure security and containment. It must be waterproof, tamper-evident, and resistant to tearing or breaking. Once removed, it cannot be opened or reused; it must be destroyed with its contents.
- A pharmacy has a full, unopened stock bottle of oxycodone/acetaminophen 5/325 mg tablets that expired last month. What is the most appropriate action for the pharmacy to take?
Answer: Segregate the expired medication from active stock and arrange for its transfer to a reverse distributor.
Expired pharmacy stock, especially controlled substances, must be physically segregated from active inventory to prevent dispensing errors. The standard procedure for disposal is to transfer it to a DEA-registered reverse distributor. Pharmacy stock cannot be placed in a patient take-back bin, and on-site destruction is now rare and requires specific DEA authorization. The return process for controlled substances is different from non-controlled drugs.
- A pharmacy sends expired diazepam (Schedule IV) and zolpidem (Schedule IV) to a reverse distributor. What documentation must the pharmacy maintain as a record of this transfer?
Answer: An invoice or other record listing the drug name, dosage form, strength, quantity, and date transferred.
The transfer of Schedule III-V controlled substances to a reverse distributor does not require a DEA Form 222. Instead, the transaction is documented on an invoice or similar record that contains all required information, similar to how these drugs are ordered from a wholesaler. The pharmacy must keep this record for at least two years.
- Which of the following best describes the primary function of a reverse distributor for a pharmacy?
Answer: To facilitate the return of expired and unwanted controlled substances for proper, compliant disposal.
The primary, DEA-regulated function of a reverse distributor is to accept expired or otherwise unwanted controlled substances from a pharmacy and process them for destruction in a manner that complies with all federal regulations. They do not typically resell these medications or act as wholesalers for active stock.
- Which of the following items is expressly forbidden for a patient to place into a pharmacy's drug collection receptacle?
Answer: Hypodermic needles and other sharps.
Drug take-back receptacles are designed for medications only. Sharps (needles, syringes, lancets) are prohibited because they pose a significant biohazard and puncture risk to personnel handling the sealed liners and at the destruction facility. Illicit drugs are also prohibited.
- The primary difference in federal paperwork requirements for transferring expired Schedule II drugs versus Schedule III-V drugs to a reverse distributor is that:
Answer: Schedule II transfers require a DEA Form 222, while Schedule III-V transfers are documented on an invoice.
This is a key regulatory distinction. The transfer of Schedule II substances requires the strict ordering and tracking provided by the DEA Form 222 (or its electronic equivalent, CSOS). The transfer of Schedule III, IV, and V substances is documented using a standard invoice or transfer record, which must be readily retrievable.
- A pharmacy is in the process of permanently closing. Which of the following is a federally compliant method for disposing of its entire remaining controlled substance inventory?
Answer: Transferring the inventory to a DEA-registered reverse distributor.
When a pharmacy closes, it must account for its entire controlled substance stock. The proper methods for disposal are to transfer the drugs to another DEA-registered pharmacy, wholesaler, or manufacturer, or to transfer them to a DEA-registered reverse distributor for destruction. The reverse distributor is the most common method for disposal of a mixed inventory.
- The complete and accurate documentation kept by a pharmacy for transferring controlled substances to a reverse distributor, including the DEA Form 222 or invoice, creates a legal:
Answer: Chain of custody.
The series of documents that track a controlled substance from the pharmacy to the reverse distributor and its ultimate destruction forms a chain of custody. This paper trail is essential for DEA compliance as it proves the medication was handled properly and not diverted at any point in the disposal process.
- According to federal law, how long must a pharmacy maintain all records related to the transfer of controlled substances to a reverse distributor?
Answer: Two years.
The Controlled Substances Act requires that all records related to controlled substances, including inventory, ordering, dispensing, and transfer/disposal records (such as invoices and executed DEA Form 222s), must be maintained for a minimum of two years from the date of the record.
- The process of a pharmacy sending outdated, damaged, or otherwise unusable controlled substances to a specialized, DEA-registered facility for destruction is known as:
Answer: Reverse distribution.
Reverse distribution is the official term for the process where a pharmacy or other DEA registrant transfers controlled substances to another DEA registrant (the reverse distributor) who is authorized to acquire controlled substances from other registrants for the purpose of return or destruction.
- A long-term care facility (LTCF) nurse brings a container of a deceased resident's discontinued controlled substances to a retail pharmacy that is an authorized collector. What is the proper procedure?
Answer: The LTCF nurse is permitted to deposit the substances into the collection receptacle.
DEA regulations specifically permit an authorized long-term care facility to dispose of a patient's controlled substances in a collection receptacle on behalf of the patient. The LTCF staff member acts as the agent of the ultimate user and is allowed to deposit the drugs into the receptacle. Pharmacy staff should not handle the substances.
- When a reverse distributor destroys controlled substances on behalf of a pharmacy, who is responsible for submitting DEA Form 41 (Registrants Inventory of Drugs Surrendered) to the DEA?
Answer: The reverse distributor who performs the destruction.
The correct answer is the reverse distributor who performs the destruction. While the pharmacy transfers the substances, the DEA-registered entity that actually destroys them is responsible for completing and submitting DEA Form 41 to document that the drugs have been rendered non-retrievable.
- A pharmacy, acting as an authorized collector, has collected patient-deposited medications in its take-back bin. Which of the following actions regarding the removed inner liner is strictly prohibited?
Answer: Opening the liner to sort the contents for inventory purposes.
The contents of a take-back receptacle are not part of the pharmacy's inventory and must not be handled, sorted, or inventoried by pharmacy staff. The sealed inner liner must be destroyed sight-unseen to protect patient privacy and prevent diversion. All other actions listed are appropriate procedures.
- A patient attempts to hand a pharmacy technician a bag containing their leftover oxycodone tablets for disposal. The pharmacy has a take-back program. What is the technician's most appropriate action?
Answer: Direct the patient to the location of the take-back receptacle and instruct them to deposit it themselves.
Pharmacy personnel are strictly prohibited from handling controlled substances that are being returned by a patient for disposal. The patient (or their agent) must maintain custody and personally deposit the medication into the authorized collection receptacle. This prevents diversion and protects the pharmacy from liability.
- A pharmacy that provides a mail-back program for the disposal of controlled substances must ensure that the packages provided to patients are:
Answer: Nondescript, tamper-evident, and have postage pre-paid.
Mail-back packages must be designed to be secure and anonymous to prevent theft during transit. They must not indicate the contents, must have a tamper-evident seal, and must be pre-addressed to the authorized destruction facility with postage paid to make it easy for the patient to use.
- A retail pharmacy wishes to install a collection receptacle for patients to dispose of unwanted pharmaceuticals, including controlled substances. Under the Secure and Responsible Drug Disposal Act, the pharmacy must first register with the DEA as a(n):
Answer: Authorized collector.
To operate a take-back program for controlled substances from ultimate users (patients), a pharmacy must modify its DEA registration to become an 'authorized collector.' This specific designation permits them to maintain a collection receptacle or manage a mail-back program.
- A patient asks a technician if they can return their unused fentanyl patches. The pharmacy is a registered authorized collector with a receptacle. The technician should instruct the patient to:
Answer: Place the patches into the designated collection receptacle themselves.
The proper procedure for a take-back program is for the ultimate user (the patient) to deposit the medication into the receptacle themselves. Pharmacy staff are prohibited from handling patient-owned controlled substances for disposal. While flushing is an option if no take-back program is available, using the authorized receptacle is the preferred method.
- What is the minimum number of qualified pharmacy employees required by federal regulation to handle and witness the removal and sealing of the inner liner from a drug take-back collection receptacle?
Answer: Two.
To ensure security and prevent diversion, the DEA requires that at least two employees of the authorized collector must be present to remove the inner liner from the collection receptacle, seal it, and prepare it for transfer or destruction. This provides a necessary witness to the process.
